FIELD

Reproductive Pathophysiology and Obstet-Gynecology

Research outline

研究室の様子1
 研究室の様子2

Graduate School Graduate School of Medical and Dental Sciences
Course Health Research Course
Field Developmental Medicine
Department Reproductive Pathophysiology and Obstet-Gynecology
Homepage http://www.kufm.kagoshima-u.ac.jp/~obgy/

Homepage

Contact

TEL.+81-99-275-5423 / FAX.+81-99-265-0507

Research interests

  • Gynecologic oncology
  • Perinatal medicine
  • Gynecologic endocrinology
  • Reproductive medicine
  • Assisted reproductive technology
  • Perimenopausal medicine

staff dummy

Professor
Name Hiroaki KOBAYASHI
Specialized field gynecologic oncology
Research interests ・子宮頸がん妊孕性温存手術、センチネルリンパ節ナビゲーションサージャリ－、子宮がんロボット手術、がん休眠化学療法、卵巣がん腹膜播種に対するカルポニン遺伝子治療

Researche Repository

staff dummy

Assistant Professor
Name Masaki KAMIO
Specialized field gynecologic oncology
Research interests the effect of HPV infection on cervical cancer

Researche Repository

Research results

Hiroaki KOBAYASHI
  1. Inhibition of AHR transcription by NF1C is affected by a single nucleotide polymorphism, and is involved in suppression of human uterine endometrial cancer. Li D, Takao T, Tsunematsu R, Morokuma S, Fukushima K, Kobayashi H, Saito T, Furue M, Wake N, Asanoma K. Oncogene 32(41): 4950-4959, 2013
  2. Phase III randomized controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102). Katsumata N, Yoshikawa H, Kobayashi H, Saito T, Kuzuya K, Nakanishi T, Yasugi T, Yaegashi N, Yokota H, Kodama S, Mizunoe T, Hiura M, Kasamatsu T, Shibata T, Kamura T, Japan Clinical Oncology Group. Br J Cancer. 108(10): 1957-1963, 2013
  3. Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: a retrospective multi-institutional study of 426 patients in Japan. Eto T, Saito T, Shimokawa M, Hatae M, Takeshima N, Kobayashi H, Kasamatsu T, Yoshikawa H, Kamura T, Konishi I: Gynecol Oncol. 131(3): 574-580, 2013
  4. Cryotherapy for massive vulvar lymphatic leakage complicated with lymphangiomas following gynecological cancer treatment. Yanazume S, Douzono H, Kubo H, Nagata T, Douchi T, Kobayashi H: Jpn J Clin Oncol. 44(11): 1116-1119, 2014
  5. Cryotherapy for massive vulvar lymphatic leakage complicated with lymphangiomas following gynecological cancer treatment. Yanazume S, Douzono H, Kubo H, Nagata T, Douchi T, Kobayashi H. Jpn J Clin Oncol. 44(11):1116-9. 2014
Masaki KAMIO
  1. Clinical usefulness of concentrated ascites reinfusion therapy (CART) for gynecological cancer patients with refractory massive ascites due to cancerous peritonitis. Togami S, Hori S, Kamio M, Matsuo T, Yoshinaga M, Douchi T. Eur J Gynaecol Oncol. 35(3):301-3. 2014
  2. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer? Togami S, Kamio M, Yanazume S, Yoshinaga M, Douchi T. Int J Gynecol Cancer. 24(6):1072-6. 2014

Homepage